PUBLICAÇÕES científicas

Molecular diagnosis in Allergology: application of the microarray tecnique

M Ferrer (1), ML Sanz [ES] (1), J Sastre (2,3), J Bartra (4,3), A del Cuvillo (5), J Montoro (6), I Jáuregui (7), I Dávila (8), J Mullol (9,3), A Valero (4,3)
(1) Departamento de Alergia e Inmunología Clínica, Clínica Universidad de Navarra, Pamplona, Spain
(2) Servicio de Alergia, Fundación Jiménez Díaz, Madrid, Spain
(3) Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES)
(4) Unitat d?Al.lèrgia, Servei de Pneumologia i Al.lèrgia Respiratòria, Hospital Clinic (ICT), Barcelona, Spain
(5) Clínica Dr. Lobatón, Cádiz, Spain
(6) Unidad de Alergia, Hospital La Plana, Vila-Real (Castellón), Spain
(7) Servicio de Alergología, Hospital de Basurto, Bilbao, Spain
(8) Servicio de Inmunoalergia, Hospital Universitario, Salamanca, Spain
(9) Unitat de Rinologia & Clínica de l?Olfacte, Servei d?Oto-rino-laringologia, Hospital Clínic Immunoal.lèrgia Respiratòria Clínica i Experimental, IDIBAPS. Barcelona, Spain

Revisão:Journal Investigational Allergology and Clinical Immunology

Data: 1/Jul/2009

Alergologia e Imunologia Clínica

RESUMEN

Recombinant and purified allergens are currently available for determining specific IgE targeted to different allergenic components. In this way it is possible to diagnose the sensitization profile of each individual patient.

The microarray technique makes it possible to determine specific IgE against multiple allergens simultaneously in one same patient, with a minimum amount of serum, and even allows the determination of IgG and IgM against the same allergens in one same serum sample. Microarray procedures are being developed not only for the determination of antibodies but also for cell activation tests. In addition, microarray technology will help explain cross-reactions, and will facilitate the evaluation of subjects in which skin tests cannot be performed. These techniques will allow a great step forward in the development of immunotherapy specifically targeted to the sensitizations found in each individual patient, yielding especially hypoallergenic forms of great immunogenic capacity, and thus improving the safety and efficacy of immunotherapy.

Lastly, microarrays will improve our understanding of the physiopathology of allergic diseases.

CITAÇÃO DO ARTIGO  J Investig Allergol Clin Immunol. 2009;19 Suppl 1:19-24

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra